We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Policy Roadmap Targets Opioid Addiction, Strengthening Generic Competition
FDA Policy Roadmap Targets Opioid Addiction, Strengthening Generic Competition
The FDA will prioritize the opioid crisis, innovation, and generic competition in the coming year, the agency said in a 2018 Strategic Policy Roadmap released Thursday.